| [1]Samartzis D, Shen FH, Goldberg EJ, et al. Is autograft the gold standard in achieving radiographic fusion in one-level anterior cervical discectomy and fusion with rigid anterior plate fixation. Spine (Phila Pa 1976). 2005; 30(15): 1756-1761.[2]Putzier M, Strube P, Funk JF, et al. Allogenic versus autologous cancellous bone in lumbar segmental spondylodesis: a randomized prospective study. Eur Spine J. 2009;18(5): 687-695.[3]Chatterjea A, Meijer G, van BC, et al. Clinical application of human mesenchymal stromal cells for bone tissue engineering. Stem Cells Int. 2010; 2010: 215625.[4]Demers C, Hamdy CR, Corsi K, et al. Natural coral exoskeleton as a bone graft substitute: a review. Biomed Mater Eng. 2002;12(1): 15-35.[5]Wildemann B, Kadow-Romacker A, Haas NP, et al. Quantification of various growth factors in different demineralized bone matrix preparations. J Biomed Mater Res A. 2007;81(2): 437-42.[6]Kasten P, Beyen I, Niemeyer P, et al. Porosity and pore size of beta-tricalcium phosphate scaffold can influence protein production and osteogenic differentiation of human mesenchymal stem cells: an in vitro and in vivo study. Acta Biomater. 2008; 4(6): 1904-1915.[7]Kim SJ, Shin YW, Yang KH, et al. A multi-center, randomized, clinical study to compare the effect and safety of autologous cultured osteoblast(Ossron) injection to treat fractures. BMC Musculoskelet Disord. 2009; 10: 20.[8]Chenite A, Chaput C, Wang D, et al. Novel injectable neutral solutions of chitosan form biodegradable gels in situ. Biomaterials. 2000; 21(21): 2155-2161.[9]Tian M, Yang Z, Kuwahara K, et al. Delivery of demineralized bone matrix powder using a thermogelling chitosan carrier. Acta Biomater. 2012;8(2): 753-762.[10]Dallari D, Savarino L, Albisinni U, et al. A prospective, randomised, controlled trial using a Mg-hydroxyapatite - demineralized bone matrix nanocomposite in tibial osteotomy. Biomaterials. 2012;33(1): 72-79.[11]Cook SD, Salkeld SL, Patron LP. Bone defect healing with an osteogenic protein-1 device combined with carboxymethylcellulose. J Biomed Mater Res B Appl Biomater. 2005;75(1): 137-145.[12]Zhao B, Katagiri T, Toyoda H, et al. Heparin potentiates the in vivo ectopic bone formation induced by bone morphogenetic protein-2. J Biol Chem. 2006;281(32): 23246-23253.[13]Li Y, Thula TT, Jee S, et al. Biomimetic mineralization of woven bone-like nanocomposites: role of collagen cross-links. Biomacromolecules. 2012;13(1): 49-59.[14]Nauth A, Ristevski B, Li R, et al.Growth factors and bone regeneration: how much bone can we expect. Injury. 2011; 42(6): 574-579.[15]Dimitriou R, Tsiridis E, Giannoudis PV. Current concepts of molecular aspects of bone healing. Injury. 2005;36(12): 1392-1404.[16]Urist MR. Bone: formation by autoinduction. Science (80- ). 1965;150(3698): 893-899.[17]Boakye M, Mummaneni PV, Garrett M, et al. Anterior cervical discectomy and fusion involving a polyetheretherketone spacer and bone morphogenetic protein. J Neurosurg Spine. 2005;2(5): 521-525.[18]Dawson E, Bae HW, Burkus JK, et al. Recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge with an osteoconductive bulking agent in posterolateral arthrodesis with instrumentation. A prospective randomized trial. J Bone Joint Surg Am. 2009;91(7): 1604-1613.[19]Clokie CM, Sandor GK. Reconstruction of 10 major mandibular defects using bioimplants containing BMP-7. J Can Dent Assoc. 2008;74(1): 67-72.[20]Li M, Liu X, Liu X, et al. Calcium phosphate cement with BMP-2-loaded gelatin microspheres enhances bone healing in osteoporosis: a pilot study. Clin Orthop Relat Res. 2010;468(7): 1978-1985.[21]Robin BN, Chaput CD, Zeitouni S, et al. Cytokine-mediated inflammatory reaction following posterior cervical decompression and fusion associated with recombinant human bone morphogenetic protein-2: a case study. Spine (Phila Pa 1976). 2010;35(23): E1350-1354.[22]Helgeson MD, Lehman RA Jr, Patzkowski JC, et al. Adjacent vertebral body osteolysis with bone morphogenetic protein use in transforaminal lumbar interbody fusion. Spine J. 2011; 11(6): 507-510.[23]Rihn JA, Patel R, Makda J, et al. Complications associated with single-level transforaminal lumbar interbody fusion. Spine J. 2009;9(8): 623-629.[24]Carragee EJ, Hurwitz EL, Weiner BK. A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. Spine J. 2011;11(6): 471-491.[25]Dawson E, Bae HW, Burkus JK, et al. Recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge with an osteoconductive bulking agent in posterolateral arthrodesis with instrumentation. A prospective randomized trial. J Bone Joint Surg Am. 2009;91(7): 1604-1613.[26]Dimar JR 2nd, Glassman SD, Burkus JK, et al. Clinical and radiographic analysis of an optimized rhBMP-2 formulation as an autograft replacement in posterolateral lumbar spine arthrodesis. J Bone Joint Surg Am. 2009;91(6): 1377-1386.[27]Carragee EJ, Bono CM, Scuderi GJ. Pseudomorbidity in iliac crest bone graft harvesting: the rise of rhBMP-2 in short- segment posterior lumbar fusion. Spine J. 2009. 9(11): 873-879.[28]Howard JM, Glassman SD, Carreon LY. Posterior iliac crest pain after posterolateral fusion with or without iliac crest graft harvest. Spine J. 2011;11(6): 534-537.[29]Peng H, Usas A, Olshanski A, et al. VEGF improves, whereas sFlt1 inhibits, BMP2-induced bone formation and bone healing through modulation of angiogenesis. J Bone Miner Res. 2005;20(11): 2017-2027.[30]Wang H, Li X, Tomin E, et al. Thrombin peptide (TP508) promotes fracture repair by up-regulating inflammatory mediators, early growth factors, and increasing angiogenesis. J Orthop Res. 2005;23(3): 671-679.[31]Poehling S, Pippig SD, Hellerbrand K, et al. Superior effect of MD05, beta-tricalcium phosphate coated with recombinant human growth/differentiation factor-5, compared to conventional bone substitutes in the rat calvarial defect model. J Periodontol. 2006;77(9): 1582-1590.[32]Nauth A, Giannoudis PV, Einhorn TA, et al. Growth factors: beyond bone morphogenetic proteins. J Orthop Trauma. 2010;24(9): 543-546.[33]Wrotniak M, Bielecki T, Gazdzik TS. Current opinion about using the platelet-rich gel in orthopaedics and trauma surgery. Ortop Traumatol Rehabil. 2007;9(3): 227-238.[34]Pierce GF, Tarpley JE, Yanagihara D, et al. Platelet-derived growth factor (BB homodimer), transforming growth factor-beta 1, and basic fibroblast growth factor in dermal wound healing. Neovessel and matrix formation and cessation of repair. Am J Pathol. 1992;140(6): 1375-1388.[35]Hakimi M, Jungbluth P, Sager M, et al. Combined use of platelet-rich plasma and autologous bone grafts in the treatment of long bone defects in mini-pigs. Injury. 2010;41(7): 717-723.[36]Parizi AM, Oryan A, Shafiei-Sarvestani Z, et al. Human platelet rich plasma plus Persian Gulf coral effects on experimental bone healing in rabbit model: radiological, histological, macroscopical and biomechanical evaluation. J Mater Sci Mater Med. 2012;23(2): 473-483.[37]Metzler P, von Wilmowsky C, Zimmermann R, et al. The effect of current used bone substitution materials and platelet-rich plasma on periosteal cells by ectopic site implantation: an in-vivo pilot study. J Craniomaxillofac Surg. 2012; 40(5): 409-415.[38]Giovanini AF, Gonzaga CC, Zielak JC, et al. Platelet-rich plasma (PRP) impairs the craniofacial bone repair associated with its elevated TGF-beta levels and modulates the co-expression between collagen III and alpha-smooth muscle actin. J Orthop Res. 2011;29(3): 457-463.[39]Bassi AP, Carvalho PS. Repair of bone cavities in dog's mandible filled with inorganic bovine bone and bioactive glass associated with platelet rich plasma. Braz Dent J. 2011;22(1): 14-20.[40]Janicki P, Kasten P, Kleinschmidt K, et al. Chondrogenic pre-induction of human mesenchymal stem cells on beta-TCP: enhanced bone quality by endochondral heterotopic bone formation. Acta Biomater. 2010;6(8): 3292-3301.[41]Dimitriou R, Jones E, McGonagle D, et al. Bone regeneration: current concepts and future directions. BMC Med. 2011;9: 66.[42]Fischer J, Kolk A, Wolfart S, et al. Future of local bone regeneration - Protein versus gene therapy. J Craniomaxillofac Surg. 2011;39(1): 54-64.[43]Guo X, Zheng Q, Kulbatski I, et al. Bone regeneration with active angiogenesis by basic fibroblast growth factor gene transfected mesenchymal stem cells seeded on porous beta-TCP ceramic scaffolds. Biomed Mater. 2006;1(3): 93-99.[44]Devescovi V, Leonardi E, Ciapetti G, et al. Growth factors in bone repair. Chir Organi Mov. 2008;92(3): 161-168.[45]Schmidmaier G, Schwabe P, Strobel C, et al. Carrier systems and application of growth factors in orthopaedics. Injury. 2008; 39 Suppl 2: S37-43.[46]Giannoudis PV, Einhorn TA, Schmidmaier G, et al. The diamond concept--open questions. Injury. 2008;39 Suppl 2: S5-8.[47]Chen Z, Ba G, Shen T, et al. Recombinant human bone morphogenetic protein-2 versus autogenous iliac crest bone graft for lumbar fusion: a meta-analysis of ten randomized controlled trials. Arch Orthop Trauma Surg. 2012;132(12): 1725-1740. |
